Royce & Associates’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.18M	Sell	1,642,368 -50,289	-3%	-$237K	0.07%	407
2025 Q4	$8.55M	Sell	1,692,657 -70,605	-4%	-$328K	0.09%	356
2025 Q3	$6.12M	Buy	1,763,262 +373,456	+27%	+$1.4M	0.06%	426
2025 Q2	$4.73M	Buy	1,389,806 +823,987	+146%	+$2.75M	0.05%	469
2025 Q1	$2.27M	Buy	565,819 +95,000	+20%	+$492K	0.02%	571
2024 Q4	$3.06M	Buy	470,819 +289,425	+160%	+$1.72M	0.03%	562
2024 Q3	$1M	Buy	181,394 +61,916	+52%	+$351K	0.01%	730
2024 Q2	$667K	Buy	119,478 +108,128	+953%	+$649K	0.01%	765
2024 Q1	$76.2K	Buy	+11,350	New	+$89.8K	﹤0.01%	864
2023 Q4	–	Sell	-87,489	Closed	-$483K	–	882
2023 Q3	$483K	Buy	87,489 +15,209	+21%	+$122K	﹤0.01%	815
2023 Q2	$617K	Buy	72,280 +27,866	+63%	+$250K	0.01%	811
2023 Q1	$408K	Buy	+44,414	New	+$478K	﹤0.01%	858